Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2026

Mar 2, 2026

31551_dirs_2026-03-02_f8d23972-7e37-4fd5-a019-61ab8a81b1ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2026-02-26

Reporting Person: Febbo Phillip G. (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-26 Common Stock A 71806 Acquired 161292 Direct
2026-02-26 Common Stock F 24486 $38.75 Disposed 136806 Direct

Footnotes

F1: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the
Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 47,863 PSUs vested on February 26, 2026, and the remaining 23,943 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date.

F2: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.